Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Preclinical evidence from lung cancer cell lines and animal models suggest that statins could have anticancer properties. We investigated whether statin users had reduced risk of cancer-specific mortality in a population-based cohort of lung cancer patients. Methods: Newly diagnosed lung cancer patients, from 1998 to 2009, were identified from English cancer registry data and linked to the UK Clinical Practice Research Datalink, providing prescription records, and to Office of National Statistics mortality data up to 2012. Cox regression models were used to calculate HRs for cancer-specific mortality and 95% confidence intervals (CI) by statin use before and after diagnosis, and to adjust these HRs for potential confounders. Results: In 3,638 lung cancer patients, there was some evidence that statin use after diagnosis was associated with reduced lung cancer–specific mortality (adjusted HR, 0.89; 95% CI, 0.78–1.02; P = 0.09). Associations were more marked after 12 prescriptions (adjusted HR, 0.81; 95% CI, 0.67–0.98; P = 0.03) and when lipophilic statins were investigated (adjusted HR, 0.81; 95% CI, 0.70–0.94; P = 0.01), but were attenuated in some sensitivity analyses. Furthermore, in 11,051 lung cancer patients, statin use before diagnosis was associated with reduced lung cancer–specific mortality (adjusted HR, 0.88; 95% CI, 0.83–0.93; P < 0.001). Conclusions: There was some evidence that lung cancer patients who used statins, and particularly simvastatin, had reduced rates of cancer-specific mortality. Impact: These findings should first be confirmed in observational studies, but provide some support for conducting randomized controlled trials of simvastatin as adjuvant cancer therapy in lung cancer patients. Cancer Epidemiol Biomarkers Prev; 24(5); 833–41. ©2015 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overadjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 3×
“Year of diagnosis 1998–2000 102 (3) 2,204 (22) 24 (3) 618 (22) 79 (7) 563 (22) 2001–2003 451 (14) 2,893 (29) 132 (15) 754 (27) 217 (19) 669 (26) 2004–2006 1,118 (34) 2,650 (26) 279 (32) 690 (25) 347 (31) 622 (25) 2007–2009 1,616 (49) 2,362 (23) 428 (50) 713 (26) 472 (42) 669 (27) Age at diagnosis <50 16 (0) 405 (4) 7…”
Validation and validity of diagnoses in the General Practice Research Database: a systematic review
Herrett, E., Thomas, S. L., Schoonen, W. M., Smeeth, L., & Hall, A. J. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03537.x · Cited by 1,109 · cited 1×
“Radiotherapy 1,028 (31) 3,197 (32) 319 (37) 1,062 (38) 377 (34) 1,004 (40) Histology Non–small cell 1,901 (58) 5,627 (56) 638 (74) 1,982 (71) 835 (75) 1,785 (71) Small cell 418 (13) 1,257 (12) 89 (10) 335 (12) 108 (10) 316 (13) Missing 968 (29) 3,225 (32) 136 (16) 458 (17) 172 (15) 422 (17) Smoking status before cance…”
Statin use and reduced cancer-related mortality
Nielsen, S. F., Nordestgaard, B. G., & Bojesen, S. E. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1201735 · Cited by 1,030
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839 · cited 3×
“Non-smoker 372 (11) 1,338 (13) 100 (12) 385 (14) 128 (11) 357 (14) Ex-smoker 1,688 (51) 3,175 (31) 439 (51) 955 (34) 525 (47) 869 (34) Current smoker 1,149 (35) 4,305 (43) 295 (34) 1,144 (41) 411 (37) 1,024 (41) Missing 78 (2) 1,291 (13) 29 (3) 291 (10) 51 (5) 269 (11) Alcohol consumption before diagnosis Never 564 (1…”
Zhou, Z., Rahme, E., Abrahamowicz, M., & Pilote, L. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi307 · Cited by 425 · cited 3×
“Year of diagnosis 1998–2000 102 (3) 2,204 (22) 24 (3) 618 (22) 79 (7) 563 (22) 2001–2003 451 (14) 2,893 (29) 132 (15) 754 (27) 217 (19) 669 (26) 2004–2006 1,118 (34) 2,650 (26) 279 (32) 690 (25) 347 (31) 622 (25) 2007–2009 1,616 (49) 2,362 (23) 428 (50) 713 (26) 472 (42) 669 (27) Age at diagnosis <50 16 (0) 405 (4) 7…”
MethodToward a Clearer Definition of Confounding
Weinberg, C. R. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116591 · Cited by 401
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Ahern, T. P., Pedersen, L., Tarp, M., Cronin-Fenton, D. P., Garne, J. P., Silliman, R. A., Sorensen, H. T., & Lash, T. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr291 · Cited by 387
Cited by
Tong, X., Tang, R., Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Yu, X., & Shi, S. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01392-3 · Cited by 883
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Moon, S.-H., Huang, C.-H., Houlihan, S. L., Regunath, K., Freed-Pastor, W. A., Morris, J. P., Tschaharganeh, D. F., Kastenhuber, E. R., Barsotti, A. M., Culp-Hill, R., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.011 · Cited by 435
Statins: a repurposed drug to fight cancer
Jiang, W., Hu, J.-W., He, X.-R., Jin, W.-L., & He, X.-Y. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02041-2 · Cited by 417
The Innovative Potential of Statins in Cancer: New Targets for New Therapies
Di Bello, E., Zwergel, C., Mai, A., & Valente, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00516 · Cited by 105
Zhou, D., Wu, Q., Qiu, H., Li, M., & Ji, Y. (2022) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2022/6177477 · Cited by 19
“Compared with the other statins, simvastatin shows the best lipophilicity and therapeutic effect [15].”
Background
Metadata
- Authors
- Cardwell, C. R., Mc Menamin, Ú., Hughes, C. M., & Murray, L. J.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2015-04-30
- Volume
- 24
- Issue
- 5
- Pages
- 833-841
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W1994648461
- Cited by
- 125
- References
- 7
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study. https://app.cochat.ai/papers/10.1158/1055-9965.epi-15-0052
- The paper
- Cardwell, C. R., Mc Menamin, Ú., Hughes, C. M., & Murray, L. J. (2015). Statin Use and Survival from Lung Cancer: A Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-15-0052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.